Skip to main content
. 2019;20(1):277–282. doi: 10.31557/APJCP.2019.20.1.277

Figure 3.

Figure 3

Immunohistochemical Detection of VEGFR-2 in Cytoplasm of Papillary Thyroid Carcinoma Cells (A) and cytoplasm of thyrocytes of nodular hyperplasia (B). Original magnifications, A, x 400 and B, x 100.